Renaissance Technologies - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 86 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$778
+21.6%
937,223
+2.5%
0.00%0.0%
Q1 2023$640
+5.4%
914,613
-23.4%
0.00%0.0%
Q4 2022$607
-99.9%
1,193,447
-17.2%
0.00%0.0%
Q3 2022$923,000
-44.5%
1,442,067
-10.7%
0.00%
-50.0%
Q2 2022$1,663,000
-30.3%
1,614,260
+27.2%
0.00%
-33.3%
Q1 2022$2,386,000
-41.3%
1,268,969
+50.4%
0.00%
-40.0%
Q4 2021$4,066,000
-25.7%
843,612
+11.5%
0.01%
-28.6%
Q3 2021$5,472,000
+2.9%
756,892
+31.4%
0.01%0.0%
Q2 2021$5,316,000
-30.1%
575,992
-6.8%
0.01%
-22.2%
Q1 2021$7,607,000
-29.3%
617,937
-19.0%
0.01%
-25.0%
Q4 2020$10,754,000
+7.0%
762,692
-8.9%
0.01%
+20.0%
Q3 2020$10,046,000
-41.8%
837,137
-19.5%
0.01%
-33.3%
Q2 2020$17,269,000
+79.1%
1,040,292
+22.8%
0.02%
+66.7%
Q1 2020$9,640,000
+8.8%
847,092
+17.8%
0.01%
+28.6%
Q4 2019$8,863,000
+305.1%
719,386
-6.3%
0.01%
+250.0%
Q3 2019$2,188,000767,8410.00%
Other shareholders

There were no reported owners of NEOLEUKIN THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders